• 1.

    Foley RN, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16:489495. doi: 10.1681/ASN.2004030203

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Arinze NV, et al. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease. J Clin Invest 2022; 132:e142260. doi: 10.1172/JCI142260

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Shashar M, et al. Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk. Sci Transl Med 2017; 9:eaam8475. doi: 10.1126/scitranslmed.aam8475

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Campesato LF, et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine. Nat Commun 2020; 11:4011. doi: 10.1038/s41467-020-17750-z

    • PubMed
    • Search Google Scholar
    • Export Citation

The Missing Link between Chronic Kidney Disease and Peripheral Arterial Disease?

Chelsea C. Estrada Chelsea C. Estrada, DO, and Sandeep K. Mallipattu, MD, FASN, are with the Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, and Renal Section, Northport VA Medical Center, Northport, NY.

Search for other papers by Chelsea C. Estrada in
Current site
Google Scholar
PubMed
Close
and
Sandeep K. Mallipattu Chelsea C. Estrada, DO, and Sandeep K. Mallipattu, MD, FASN, are with the Division of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, and Renal Section, Northport VA Medical Center, Northport, NY.

Search for other papers by Sandeep K. Mallipattu in
Current site
Google Scholar
PubMed
Close
Restricted access
Save